FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214649620> ?p ?o ?g. }

• W4214649620 endingPage "1269" @default.
• W4214649620 startingPage "1269" @default.
• W4214649620 abstract "Diacylglycerol kinase α (DGKα) inhibition may be particularly relevant for the treatment of glioblastoma (GBM), a relatively common brain malignancy incurable with current therapies. Prior reports have shown that DGKα inhibition has multiple direct activities against GBM cells, including suppressing the oncogenic pathways mTOR and HIF-1α. It also inhibits pathways associated with the normally treatment-resistant mesenchymal phenotype, yielding preferential activity against mesenchymal GBM; this suggests possible utility in combining DGKα inhibition with radiation and other therapies for which the mesenchymal phenotype promotes resistance. The potential for DGKα inhibition to block or reverse T cell anergy also suggests the potential of DGKα inhibition to boost immunotherapy against GBM, which is generally considered an immunologically cold tumor. A recent report indicates that DGKα deficiency increases responsiveness of macrophages, indicating that DGKα inhibition could also have the potential to boost macrophage and microglia activity against GBM-which could be a particularly promising approach given the heavy infiltration of these cells in GBM. DGKα inhibition may therefore offer a promising multi-pronged attack on GBM, with multiple direct anti-GBM activities and also the ability to boost both adaptive and innate immune responses against GBM. However, both the direct and indirect benefits of DGKα inhibition for GBM will likely require combinations with other therapies to achieve meaningful efficacy. Furthermore, GBM offers other challenges for the application of DGKα inhibitors, including decreased accessibility from the blood-brain barrier (BBB). The ideal DGKα inhibitor for GBM will combine potency, specificity, and BBB penetrability. No existing inhibitor is known to meet all these criteria, but the strong potential of DGKα inhibition against this lethal brain cancer should help drive development and testing of agents to bring this promising strategy to the clinic for patients with GBM." @default.
• W4214649620 created "2022-03-02" @default.
• W4214649620 creator A5076042525 @default.
• W4214649620 date "2022-03-01" @default.
• W4214649620 modified "2023-09-30" @default.
• W4214649620 title "Delivering Glioblastoma a Kick—DGKα Inhibition as a Promising Therapeutic Strategy for GBM" @default.
• W4214649620 cites W1528827595 @default.
• W4214649620 cites W1534992900 @default.
• W4214649620 cites W1800095175 @default.
• W4214649620 cites W1964021043 @default.
• W4214649620 cites W1971674000 @default.
• W4214649620 cites W1972096189 @default.
• W4214649620 cites W1984906223 @default.
• W4214649620 cites W1985952396 @default.
• W4214649620 cites W1989476960 @default.
• W4214649620 cites W1997023267 @default.
• W4214649620 cites W1997636185 @default.
• W4214649620 cites W2008346251 @default.
• W4214649620 cites W2017096529 @default.
• W4214649620 cites W2018109711 @default.
• W4214649620 cites W2024672608 @default.
• W4214649620 cites W2024850003 @default.
• W4214649620 cites W2025183726 @default.
• W4214649620 cites W2025317543 @default.
• W4214649620 cites W2027777964 @default.
• W4214649620 cites W2030017878 @default.
• W4214649620 cites W2032672495 @default.
• W4214649620 cites W2035756665 @default.
• W4214649620 cites W2043499184 @default.
• W4214649620 cites W2049471272 @default.
• W4214649620 cites W2050698267 @default.
• W4214649620 cites W2055557739 @default.
• W4214649620 cites W2077919059 @default.
• W4214649620 cites W2079724447 @default.
• W4214649620 cites W2090329639 @default.
• W4214649620 cites W2096287682 @default.
• W4214649620 cites W2100567246 @default.
• W4214649620 cites W2102888099 @default.
• W4214649620 cites W2111264907 @default.
• W4214649620 cites W2113942802 @default.
• W4214649620 cites W2118841522 @default.
• W4214649620 cites W2127745545 @default.
• W4214649620 cites W2128469603 @default.
• W4214649620 cites W2134035592 @default.
• W4214649620 cites W2137979737 @default.
• W4214649620 cites W2144487043 @default.
• W4214649620 cites W2161112598 @default.
• W4214649620 cites W2161289668 @default.
• W4214649620 cites W2260497117 @default.
• W4214649620 cites W2303572581 @default.
• W4214649620 cites W2402659606 @default.
• W4214649620 cites W2405402430 @default.
• W4214649620 cites W2412871407 @default.
• W4214649620 cites W2539781154 @default.
• W4214649620 cites W2564096649 @default.
• W4214649620 cites W2567424265 @default.
• W4214649620 cites W2732161321 @default.
• W4214649620 cites W2734384637 @default.
• W4214649620 cites W2762106414 @default.
• W4214649620 cites W2789903971 @default.
• W4214649620 cites W2793992337 @default.
• W4214649620 cites W2911752971 @default.
• W4214649620 cites W2913623258 @default.
• W4214649620 cites W2924105651 @default.
• W4214649620 cites W2981309405 @default.
• W4214649620 cites W2981667311 @default.
• W4214649620 cites W2994477859 @default.
• W4214649620 cites W2995682532 @default.
• W4214649620 cites W3006163888 @default.
• W4214649620 cites W3119067900 @default.
• W4214649620 cites W3131835685 @default.
• W4214649620 cites W3174365286 @default.
• W4214649620 cites W3191401694 @default.
• W4214649620 cites W3197911672 @default.
• W4214649620 cites W3203461006 @default.
• W4214649620 cites W3213993579 @default.
• W4214649620 cites W4200304711 @default.
• W4214649620 cites W4210615035 @default.
• W4214649620 cites W4211022769 @default.
• W4214649620 cites W4239155095 @default.
• W4214649620 doi "https://doi.org/10.3390/cancers14051269" @default.
• W4214649620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35267577" @default.
• W4214649620 hasPublicationYear "2022" @default.
• W4214649620 type Work @default.
• W4214649620 citedByCount "1" @default.
• W4214649620 countsByYear W42146496202023 @default.
• W4214649620 crossrefType "journal-article" @default.
• W4214649620 hasAuthorship W4214649620A5076042525 @default.
• W4214649620 hasBestOaLocation W42146496201 @default.
• W4214649620 hasConcept C104317684 @default.
• W4214649620 hasConcept C142724271 @default.
• W4214649620 hasConcept C145059251 @default.
• W4214649620 hasConcept C195794163 @default.
• W4214649620 hasConcept C198826908 @default.
• W4214649620 hasConcept C203014093 @default.
• W4214649620 hasConcept C20518536 @default.
• W4214649620 hasConcept C2776914184 @default.
• W4214649620 hasConcept C2777701055 @default.

• next